Calendar

Date TBD

ACTIVE_NOT_RECRUITINGphase readoutNCT03767348: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Sponsor: Replimune, Inc.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07504848: Stroke Mobility and Caregiver Outcomes

Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Stroke, Caregiver

full page →ctgov ↗

COMPLETEDphase readoutNCT04481048: Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: PHASE2. Conditions: Neurofibromatosis 1

full page →ctgov ↗

COMPLETEDphase readoutNCT04818255: STIM+: PET Biomarker Education & Disclosure

Sponsor: University of Michigan. Phase: NA. Conditions: Mild Cognitive Impairment, Dementia; Alzheimer's Type (Etiology)

full page →ctgov ↗

RECRUITINGphase readoutNCT07446855: Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Solid Tumours

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06782126: A Study Protocol for the Implementation and Evaluation of a Self-management Support Program in Burns Aftercare for Burn Survivors in the Netherlands

Sponsor: Martini Hospital Groningen. Phase: . Conditions: Burns

full page →ctgov ↗

RECRUITINGphase readoutNCT03269578: Sample Collection and Tracking for the Developmental Therapeutics Clinic

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Neoplasms, Lymphoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07436585: CGM-Guided Acarbose for Painful Diabetic Neuropathy

Sponsor: Shifa International Hospital. Phase: PHASE1. Conditions: Diabetes, Diabetes Complications, Diabetic Neuropathy

full page →ctgov ↗

RECRUITINGphase readoutNCT07356843: Palliative Care for People With HF

Sponsor: Indiana University. Phase: . Conditions: Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic

full page →ctgov ↗

COMPLETEDphase readoutNCT07206485: Vibroacoustic Therap in Patients With Stroke

Sponsor: October 6 University. Phase: NA. Conditions: Stroke

full page →ctgov ↗

RECRUITINGphase readoutNCT07074743: Evaluate the Feasibility and Effectiveness of a Community-based Care Bundle in Managing and Preventing Pressure Injuries

Sponsor: Singapore General Hospital. Phase: NA. Conditions: Pressure Injuries, Caregiver, Community Dwelling Older Adult

full page →ctgov ↗

COMPLETEDphase readoutNCT07543315: Low Versus High Dose OnabotulinumtoxinA for Chronic Anal Fissure

Sponsor: Tanta University. Phase: PHASE3. Conditions: Chronic Anal Fissure

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07626515: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗

COMPLETEDphase readoutNCT00687115: Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE2. Conditions: Obesity, Diet Therapy, Weight Loss, Weight Gain, Nutrition Therapy

full page →ctgov ↗

WITHDRAWNphase readoutNCT04701515: Cardiovascular Manifestations of COVID-19

Sponsor: Methodist Health System. Phase: . Conditions: COVID-19

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06250335: Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: ICB-refractory Melanoma

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06956508: Prophylactic TBR on Phantom Limb Pain

Sponsor: OrthoCarolina Research Institute, Inc.. Phase: NA. Conditions: Phantom Limb Pain After Amputation

full page →ctgov ↗

RECRUITINGphase readoutNCT05492825: IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Substance Use Disorders, Chronic Pain, Opioid Use Disorder, Back Pain Lower Back Chronic

full page →ctgov ↗

COMPLETEDphase readoutNCT04365725: Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: COVID-19

full page →ctgov ↗

COMPLETEDphase readoutNCT06818825: Nudging High Emergency Department Utilizers to Consider Non-emergent Healthcare Resources

Sponsor: Geisinger Clinic. Phase: NA. Conditions: Emergency Service, Hospital

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07423117: A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Sponsor: IntoCell, Inc. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Metastatic Solid Tumor

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT05165940: Facilitating Transition to Recommended PTSD Treatment

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD

full page →ctgov ↗

RECRUITINGphase readoutNCT05279040: Trikafta Exercise Study in Cystic Fibrosis

Sponsor: University of British Columbia. Phase: . Conditions: Cystic Fibrosis, Lung Diseases

full page →ctgov ↗

COMPLETEDphase readoutNCT03016689: The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development

Sponsor: University of Minnesota. Phase: . Conditions: Cystic Fibrosis

full page →ctgov ↗

RECRUITINGphase readoutNCT05440617: Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Acute Ovarian Failure, Infertility, Early Menopause And Infertility In Females After Treatment For Childhood Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06680817: A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema

full page →ctgov ↗

RECRUITINGphase readoutNCT05755217: Renal Ultrasound Response After Chocolate Consumption

Sponsor: Gregoire Wuerzner; MD. Phase: NA. Conditions: Chocolate Consumption

full page →ctgov ↗

COMPLETEDphase readoutNCT04669912: COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management

Sponsor: Centre Hospitalier Sud Francilien. Phase: . Conditions: Type 1 Diabetes

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05405712: Mobile Peer Support for OUD Recovery

Sponsor: Brown University. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗

COMPLETEDphase readoutNCT07375719: Nuclear Abnormalities in Gingival Epithelial Cells in Relation to Periodontal Disease

Sponsor: Çankırı Karatekin University. Phase: . Conditions: Diabetes (DM), Periodontitis, Periodontitis (Stage 3), Micronuclei Count

full page →ctgov ↗

COMPLETEDphase readoutNCT05033119: PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

Sponsor: Ulla Schierup Nielsen. Phase: . Conditions: Hyperprolactinemia, Puberty Disorders, Metabolic Syndrome, Growth Disorders, Antipsychotics and Neuroleptics Toxicity

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07367919: The Effect of a Digital Literacy Program on Problematic Internet Use, Emotion Regulation, and Loneliness in Adolescents: A Randomized Controlled Trial

Sponsor: Ataturk University. Phase: NA. Conditions: Healthy Adolescents

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05238519: Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

Sponsor: Essentia Health. Phase: PHASE3. Conditions: Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07597928: A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy Adults, Healthy

full page →ctgov ↗

WITHDRAWNphase readoutNCT03974828: Telemedicine Notifications With Machine Learning for Postoperative Care

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Surgery--Complications, Perioperative/Postoperative Complications, Acute Kidney Injury, Hospital Mortality

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07027267: Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery

Sponsor: Spirair, Inc. Phase: NA. Conditions: Sinus Endoscopic Surgery, Turbinate

full page →ctgov ↗

RECRUITINGphase readoutNCT06998407: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Sponsor: Avenzo Therapeutics, Inc.. Phase: PHASE1. Conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02177292: High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06930092: RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Ischemic Cardiomyopathy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04898634: A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Prostatic Neoplasms

full page →ctgov ↗

RECRUITINGphase readoutNCT07256444: Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07514234: Optimal Allogeneic PRP Concentration for Oocyte In Vitro Maturation in Women With PCOS

Sponsor: Gadjah Mada University. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗

COMPLETEDphase readoutNCT07454109: The Effect of a Stress Coping Training Program for University Students

Sponsor: Hacettepe University. Phase: NA. Conditions: Stress

full page →ctgov ↗

RECRUITINGphase readoutNCT07585799: Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

Sponsor: Óscar Cano Pérez. Phase: NA. Conditions: Bradycardia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07580963: Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Ureteral Stent-Related Symptom

full page →ctgov ↗

RECRUITINGphase readoutNCT07527793: Monitoring Changes in Blood Circulating Metabolites Using Minimally Invasive Techniques

Sponsor: Örebro University, Sweden. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗

COMPLETEDphase readoutNCT06275893: IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

Sponsor: Implicit Bioscience. Phase: PHASE1. Conditions: Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Left Ventricular Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy 1, Arrhythmogenic Cardiomyopathy, ACM, ARVC, PKP2

full page →ctgov ↗

RECRUITINGphase readoutNCT06670521: Corticosteroids for Post-Extubation Dysphagia

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Dysphagia, Laryngeal Edema

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06716021: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Sponsor: Milestone Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Atrial Fibrillation

full page →ctgov ↗

RECRUITINGphase readoutNCT07333521: Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Isolated Non-acquired Growth Hormone Deficiency

full page →ctgov ↗

← prev

page 50 of 94

Date TBD